FDA APPROVES FIRST TREATMENT FOR NONMETASTATIC, CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Aschenbrenner, Diane S.
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2018年 / 118卷 / 06期
关键词：
D O I：
10.1097/01.NAJ.0000534848.12514.1c
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] FDA Approves Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (09) : 498 - 498
  • [2] An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer
    Brave, Michael
    Weinstock, Chana
    Brewer, Jamie R.
    Chi, Dow-Chung
    Suzman, Daniel L.
    Cheng, Joyce
    Zhang, Lijun
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Kluetz, Paul G.
    Pazdur, Richard
    Beaver, Julia A.
    CLINICAL CANCER RESEARCH, 2020, 26 (18) : 4717 - 4722
  • [3] Nonmetastatic Castration-Resistant Prostate Cancer
    Hong, Jun Hyuk
    Kim, Isaac Y.
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (03) : 153 - 160
  • [4] Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Altavilla, Amelia
    Casadei, Chiara
    Lolli, Cristian
    Menna, Cecilia
    Ravaglia, Giorgia
    Gurioli, Giorgia
    Farolfi, Alberto
    Brighi, Nicole
    Conteduca, Vincenza
    Burgio, Salvatore Luca
    Schepisi, Giuseppe
    Rossi, Lorena
    Gargiulo, Stefania
    Lisotti, Ivana
    De Giorgi, Ugo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2091 - 2099
  • [5] FDA Approves Pluvicto/Locametz for Metastatic Castration-Resistant Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) : 13N - 13N
  • [6] Treatment Approaches for Nonmetastatic Castration-Resistant Prostate Cancer
    Yildizhan, Mehmet
    Gemalmaz, Hakan
    Ertek, Mehmet Sirin
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (02): : 120 - 127
  • [7] Recent Updates in the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
    Berger, Aaron
    ONCOLOGY-NEW YORK, 2021, 35 (12): : 846 - 848
  • [8] Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
    Fizazi, Karim
    Shore, Neal
    Tammela, Teuvo L.
    Ulys, Albertas
    Vjaters, Egils
    Polyakov, Sergey
    Jievaltas, Mindaugas
    Luz, Murilo
    Alekseev, Boris
    Kuss, Iris
    Kappeler, Christian
    Snapir, Amir
    Sarapohja, Toni
    Smith, Matthew R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (13) : 1235 - 1246
  • [9] Managing Nonmetastatic Castration-resistant Prostate Cancer
    Mateo, Joaquin
    Fizazi, Karim
    Gillessen, Silke
    Heidenreich, Axel
    Perez-Lopez, Raquel
    Oyen, Wim J. G.
    Shore, Neal
    Smith, Matthew
    Sweeney, Christopher
    Tombal, Bertrand
    Tomlins, Scott A.
    de Bono, Johann S.
    EUROPEAN UROLOGY, 2019, 75 (02) : 285 - 293
  • [10] Management of nonmetastatic castration-resistant prostate cancer
    Traboulsi, Samer L.
    Saad, Fred
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) : 366 - 371
12345